SCHEMBL798487

SCHEMBL798487

c1ccc(-c2cc3cnc(N4CCCNCC4)nc3s2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKCI P41743 2/20 0.50
HTR1A P08908 2/20 0.44
HTR7 P34969 1/20 0.44
HTR2B P41595 1/20 0.44
HTR3A P46098 1/20 0.44
HTR6 P50406 1/20 0.44
CHRNB2 P17787 1/20 0.44
CHRNA4 P43681 1/20 0.44
ALDH1A1 P00352 7/20 0.44
KDM4E B2RXH2 3/20 0.44
GAA P10253 1/20 0.44
CHEK1 O14757 2/20 0.43
CDK7 P50613 1/20 0.43
MAPK1 P28482 2/20 0.43
CYP1A2 P05177 3/20 0.43
CASP1 P29466 3/20 0.43
CASP7 P55210 3/20 0.43
HIF1A Q16665 3/20 0.43
HSD17B10 Q99714 3/20 0.43
HPGD P15428 3/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL798319 0.95 CHEK1 (0.46) PRKCIHTR1AHTR7ALDH1A1KDM4E
SCHEMBL793765 0.83 ALDH1A1 (0.45) HTR1AHTR7HTR2BHTR3AHTR6
SCHEMBL653602 0.81 ALDH1A1 (0.40) PRKCIALDH1A1KDM4EGAAMAPK1
SCHEMBL656278 0.79 ALDH1A1 (0.37) PRKCIHTR1AALDH1A1KDM4EGAA
SCHEMBL6770810 0.73 CHRNB2 (0.60) HTR1AHTR7HTR2BHTR3AHTR6
SCHEMBL656735 0.70 IKBKB (0.44) ALDH1A1KDM4EGAAMAPK1HSD17B10
SCHEMBL9400977 0.69 TAAR1 (0.64) HTR1AHTR7HTR2BHTR3AHTR6
SCHEMBL655041 0.68 USP2 (0.35) HTR1AHTR7ALDH1A1MAPK1CYP1A2
SCHEMBL793832 0.67 HTR2C (0.57) ALDH1A1KDM4EMAPK1CYP1A2CASP1
SCHEMBL10219367 0.67 CHEK1 (0.56) PRKCIHTR1AHTR7HTR2BHTR3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2616077-A1 ANTI-CANCER ACTIVITY OF NOVEL BICYCLIC HETEROCYCLES Katholieke Universiteit Leuven, K.U. Leuven R&D (BE) 2013-07-24 EP disclosed
EP-2575969-A1 ANTIVIRAL ACTIVITY OF NOVEL BICYCLIC HETEROCYCLES Katholieke Universiteit Leuven, K.U. Leuven R&D (BE) 2013-04-10 EP disclosed
WO-2012035423-A1 ANTI-CANCER ACTIVITY OF NOVEL BICYCLIC HETEROCYCLES KATHOLIEKE UNIVERSITEIT LEUVEN, K.U. LEUVEN R&D (BE) 2012-03-22 WO disclosed
EP-2405973-A2 THIAZOLOPYRIMIDINE MODULATORS AS IMMUNOSUPPRESSIVE AGENTS Katholieke Universiteit Leuven, K.U. Leuven R&D (BE) 2012-01-18 EP disclosed
WO-2011147753-A1 ANTIVIRAL ACTIVITY OF NOVEL BICYCLIC HETEROCYCLES KATHOLIEKE UNIVERSITEIT LEUVEN, K.U.LEUVEN R&D (BE) 2011-12-01 WO disclosed